CLINICAL_TRIALS
trial_result
· 2009-02-02
Clinical Trial Update: A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy [Phase 3]
Summary
A Phase 3 trial evaluating recombinant human erythropoietin for chemotherapy-induced anemia in cancer patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chugai Pharmaceutical | Conditions: Chemotherapy Induced Anemia | Phase 3 | Status: COMPLETED